Latest News About - Anticoagulant

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Sunday, April 30, 2017

9:04:00 AM CEST

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
lb
lo
lt
lv
mk
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Most reported countries (24h)

Theme countries

AlertLevel (24h)

Alert level graph

 Previous 14 days average

Alert level:
 high   medium   low

Quotes... Extracted quotes

George Miller said: "Blood clots are related to 1 in 4 deaths worldwide. Given the potential for serious and life-threatening events like stroke, pulmonary embolism, and deep vein thrombosis among people at risk for clots, non-vitamin K antagonist oral anticoagulants such as Xarelto are a critical treatment option. For patients who have previously suffered a VTE, the risk of experiencing another event is up to 10 percent during the first year if anticoagulant therapy is stopped, and this figure rises to 20 percent within three years," External link

bayer Saturday, April 29, 2017 4:59:00 AM CEST

Paul Burton said: "For those people who have had a VTE and stop anticoagulant therapy, as many as 10 percent of them will experience another VTE within one year and 20 percent within three years," External link

prnewswire Friday, April 28, 2017 10:52:00 PM CEST

Werner Baumann said: “We took another major strategic step forward with the agreed acquisition of Monsanto, which is aimed at further strengthening Bayer,” External link

seedquest Friday, April 28, 2017 8:03:00 PM CEST

Werner Baumann said: “Due to the gratifying development of business, we now believe these five products can do even better than we had already anticipated,” External link

seedquest Friday, April 28, 2017 8:03:00 PM CEST

Werner Baumann said: “As our businesses are highly complementary in terms of both products and geographical focus, and there are only a small number of overlaps, we remain confident that we will be granted all the necessary clearances,” External link

seedquest Friday, April 28, 2017 8:03:00 PM CEST

Werner Baumann said: “All segments improved their operating performance. Business development at Pharmaceuticals was very good,” External link

seedquest Friday, April 28, 2017 8:03:00 PM CEST

Werner Baumann explained: “We expect the Bayer Group to continue its positive performance and are targeting another record year,” External link

seedquest Friday, April 28, 2017 8:03:00 PM CEST

Werner Baumann explained: “These efforts are paying off, as evidenced by our development pipelines,” External link

seedquest Friday, April 28, 2017 8:03:00 PM CEST

Werner Baumann stated: “The acquisition of Monsanto is the perfect fit for our strategy,” External link

seedquest Friday, April 28, 2017 8:03:00 PM CEST

Werner Baumann said: “At Pharmaceuticals, we once again benefited from the very good performance of our key growth products,” External link

seedquest Friday, April 28, 2017 2:09:00 AM CEST

Werner Baumann said: “Our key growth products were once again especially successful, registering combined growth of 20 percent on a currency-adjusted basis,” External link

seedquest Friday, April 28, 2017 2:09:00 AM CEST

Werner Baumann noted: “We achieved double-digit percentage sales gains for several products at Consumer Health as well,” External link

seedquest Friday, April 28, 2017 2:09:00 AM CEST

Werner Baumann said: “Crop Science benefited primarily from encouraging performance in North America,” External link

seedquest Friday, April 28, 2017 2:09:00 AM CEST

Werner Baumann said: “At Pharmaceuticals, we once again benefited from the very good performance of our key growth products,” External link

pharmpro Thursday, April 27, 2017 4:37:00 PM CEST

Werner Baumann said: “Our key growth products were once again especially successful, registering combined growth of 20 percent on a currency-adjusted basis,” External link

pharmpro Thursday, April 27, 2017 4:37:00 PM CEST

Patricio González afirmó: "Los niños pequeños también pueden sentirse atraídos por ellos y comerlos, como ya ha ocurrido con varias mascotas" External link

lanuevaespana Wednesday, April 26, 2017 9:42:00 AM CEST

Most associated names

Daily number of articles in this category

Trend data not available for this selection.